Huge variations between countries in time for reimbursement decisions on new cancer drugs
byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin
Updated on: December 18,2023
Huge variations between countries in time for reimbursement decisions on new cancer drugs
byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin
Updated on:December 18,2023
